<DOC>
	<DOC>NCT01134159</DOC>
	<brief_summary>Multicenter, retrospective registry to collect 9-12 month follow-up data to evaluate major adverse cardiac events in patients whom have undergone percutaneous coronary intervention and received either Taxus Liberte or Xience V.</brief_summary>
	<brief_title>Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience V</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Patients 18 years of age or older, both genders Underwent PCI with Taxus Liberte (alone) or Xience (alone) Underwent PCI with a nonTaxus Liberte or Xience V DES during the same procedure Received both TaxusLiberte and XienceV during the same index procedure Patients not taking, or unable to take, dual antiplatelet therapy (aspirin plus clopidogrel or prasugrel).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>